Panzyga is a Intravenous Solution in the Plasma Derivative category. It is labeled and distributed by Octapharma Usa Inc. The primary component is Human Immunoglobulin G.
Product ID | 68982-822_1db52a61-d294-2673-1e73-d47e89ca3d24 |
NDC | 68982-822 |
Product Type | Plasma Derivative |
Proprietary Name | Panzyga |
Generic Name | Immune Globulin Intravenous (human) |
Dosage Form | Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2018-11-12 |
Marketing Category | BLA / |
Application Number | BLA125587 |
Labeler Name | Octapharma USA Inc |
Substance Name | HUMAN IMMUNOGLOBULIN G |
Active Ingredient Strength | 100 mg/mL |
Pharm Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2018-11-12 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0069-1011 | Panzyga | immune globulin intravenous (human) |
0069-1109 | Panzyga | immune globulin intravenous (human) |
0069-1224 | Panzyga | immune globulin intravenous (human) |
0069-1312 | Panzyga | immune globulin intravenous (human) |
0069-1415 | Panzyga | immune globulin intravenous (human) |
0069-1558 | Panzyga | immune globulin intravenous (human) |
68982-820 | Panzyga | immune globulin intravenous (human) |
68982-822 | Panzyga | immune globulin intravenous (human) |
61953-0005 | FLEBOGAMMA DIF | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) |
0944-2623 | GAMMAGARD | Immune Globulin Intravenous (Human) |
0944-2625 | GAMMAGARD | Immune Globulin Intravenous (Human) |
0944-2627 | GAMMAGARD | Immune Globulin Intravenous (Human) |
0944-2656 | GAMMAGARD | Immune Globulin Intravenous (Human) |
0944-2658 | GAMMAGARD | Immune Globulin Intravenous (Human) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PANZYGA 79148226 4630483 Live/Registered |
Octapharma AG 2014-04-03 |